Current Status of Medical Pleuroscopy

Department of Respiratory Medicine, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester LE3 9QP, Leicestershire, UK.
Clinics in chest medicine (Impact Factor: 2.07). 03/2010; 31(1):165-72, Table of Contents. DOI: 10.1016/j.ccm.2009.10.001
Source: PubMed


Medical pleuroscopy (MP) offers a safe and minimally invasive tool for interventional pulmonologists. It allows diagnosis of unexplained effusion, while at the same time allowing drainage and pleurodesis. It can also help in the diagnosis of diffuse interstitial disease or associated peripheral lung abnormality in the presence of effusion. It can have a therapeutic role in pneumothorax and hyperhidrosis or chronic pancreatic pain. This article reviews the technical aspects and range of applications of MP.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatic hydrothorax (HH) is an infrequent but a well-known complication of portal hypertension in patients with end-stage liver disease. The estimated prevalence of HH is around 4–6 % in cirrhotics. Thoracentesis and pleural fluid analysis is a must for establishing the diagnosis of this transudative effusion in the absence of primary cardiopulmonary disease. Management strategies include sodium restriction, diuretics, thoracentesis, transjugular intrahepatic portosystemic shunt, pleurodesis, and video assisted thoracic surgery in selected patients. Liver transplantation remains the ultimate definitive management paradigm. Refractory HH thus warrants prompt consideration of liver transplantation.
    Hepatology International 03/2012; 7(1). DOI:10.1007/s12072-012-9398-8 · 1.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the historical evolution of thoracoscopy, which was initiated exactly one century ago by Hans Christian Jacobaeus, two distinct periods can be identified: one between 1910 and 1955, characterised by its use for the lysis of pleural adhesions to obtain therapeutic pneumothorax in lung tuberculosis, and the subsequent period which has seen the development of diagnostic applications, principally due to pulmonologists and, after 1990, the start of an exclusively surgical thoracoscopy called video-assisted thoracoscopic surgery or VATS to perform video-assisted interventions.
    Respiration 04/2011; 82(2):187-92. DOI:10.1159/000326066 · 2.59 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Interventional pulmonology (IP) allows comprehensive assessment of patients with benign and malignant airway, lung parenchymal and pleural disease. This relatively new branch of pulmonary medicine utilises advanced diagnostic and therapeutic techniques to treat patients with pulmonary diseases. Endobronchial ultrasound revolutionized assessment of pulmonary nodules, mediastinal lymphadenopathy and lung cancer staging allowing minimally-invasive, highly accurate assessment of lung parenchymal and mediastinal disease, with both macro- and microscopic tissue characterization including molecular signature analysis. High spatial resolution, new endobronchial imaging techniques including Autofluorescence Bronchoscopy (ABI), Narrow Band Imaging (NBI), Optical Coherence Tomography and confocal microscopy enable detailed evaluation of airways with increasing role in detection and treatment of malignancies arising in central airways. Precision in peripheral lesion localization has been increased through innovative navigational techniques including Navigational Bronchoscopy (NB) and Electromagnetic Navigation (EMN). Pleural diseases can be assessed with the use of non-invasive pleural ultrasonography, with high sensitivity and specificity for malignant disease detection. Medical pleuroscopy is a minimally-invasive technique improving diagnostic safety and precision of pleural disease and pleural effusion assessment. In this review we discuss the newest advances in diagnostic modalities utilized in IP, indications for their use, their diagnostic accuracy, efficacy, safety and challenges in application of these technologies in assessment of thoracic diseases. © 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.
    Respirology 06/2012; 18(1). DOI:10.1111/j.1440-1843.2012.02211.x · 3.35 Impact Factor
Show more